<?xml version="1.0" encoding="UTF-8"?><html xmlns:h="http://www.w3.org/1999/xhtml" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
   <head>
      <style type="text/css">
         	     		 
         	    a                          {background : #ffffff; }
         	    article                    {border-style : dotted; border-width : 2px; }
         		 	
         		 	div                        {background : #ffffcc;}
         		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
         		 	div.ack                    {border-style : solid ; border-color : red; margin
         : 2em; }
         		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin
         1em;}
         		 	div.boxed-text             {margin : 5em; border-style : solid;}
         		 	div.contrib-group          {margin : 1em; }
         		 	div.fig                    {border-style : solid; border-width : 2px; margin :
         2em; }
         		 	div.funding                {font-weight : bold ; font-size : 16pt;}
         		 	div.given-names            {font-style : italic;}
         		 	div.intro                  {border-style : inset; margin : 5px;}
         		 	div.introduction           {border-style : inset; margin : 5px;}
         		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin
         1em;}
         		 	div.journal-title-group    {background : #ffeeee;}
         		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
         		 	div.kwd                    {font-style : italic}
         		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
         		 	div.name                   {font-weight : bold;}
         		 	div.alt-title              {font-style : italic; font-size : 12px;}
         		 	
         		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
         		 	div.title                  {font-family : courier; font-weight : bold;
         		 	                            font-size : 16pt; margin : 5px;}
         		 	
         		 	div.materials_methods      {border-style : double; margin : 5px; }
         		 	div.methods                {border-style : double; margin : 5px; }
         		 	
         		 	div.results                {border-style : solid; margin : 5px;}
         		 	div.background             {border-style : dotted; margin : 5px;}
         		 	
         		 	div.discussion             {border-style : groove; margin : 5px;}
         		 	div.conclusion             {border-style : ridge; margin : 5px;}
         		 	div.conclusions             {border-style : ridge; margin : 5px;}
         		 	div.supplementary-material {border-style : inset; margin : 5px;}
         		 	div.abbreviations          {border-style : double; border-color : red; margin
         : 5px;}
         		 	div.competinginterests     {border-style : double; border-color : blue; margin
         : 5px;}
         		 	div.acknowledgements       {border-style : double; border-color : green; margin
         : 5px;}
         		 	div.authors_contributions   {border-style : double; border-color : purple; margin
         : 5px;}
         		 	
         		 	div.publisher              {border-style : outset; margin : 5px;}
         		 	div.fn-type-conflict       {background : #f88; }
         		 	div.fn-type-con            {background : #ddf; }
         		 	div.fn-type-other          {background : #ddd; }
         		 	
         		 	div.unknown                {background : #ffd;
         									 	  border-style : solid;
         									 	  border-width : 1px;
         									 	  padding : 2 px;}
         		 	  
         	    table                      {background : #ffffdd;}
         		 	tr                         {background : #ddddff; padding : 1px;}
         		 	
         		 	span                       {background : #ffcccc;}
         		 	
         		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
         		 	span.collab                {background : #ddffff; }
         		 	span.comment               {font-family : courier; font-size : 6px; background
         : #ffaaff;}
         		 	span.contrib               {background : #ffffff;}
         		 	span.corresp               {background : #ddffdd; }
         		 	span.doi                   {background : #ffffff;}
         		 	span.email                 {font-family : courier; }
         		 	span.etal                  {font-style : italic;}
         		 	span.fpage                 {font-family : courier;}
         		 	span.given-names           {background : #ffffff;}
         		 	span.iso-abbrev            {background : #ffffff;}
         		 	span.issn-epub             {background : #ffffff;}
         		 	span.issn-ppub             {background : #ffffff;}
         		 	span.journal-title         {background : #ffffff;}
         		 	span.lpage                 {font-family : courier;}
         		 	span.mixed-article-title   {font-style : italic ;}
         		 	span.nlm-ta                {background : #ffffff;}
         		 	span.pmc                   {background : #ffffff;}
         		 	span.pmcid                 {background : #ffffff;}
         		 	span.pmid                  {background : #ffffff;}
         		 	span.publisher             {background : #ffffff;}
         		 	span.publisher-id          {background : #ffffff;}
         		 	span.publisher-name        {background : #ffffff;}
         		 	span.source                {background : #ffffff;}
         		 	span.subject               {background : #ffffff;}
         		 	span.surname               {background : #ffffff;}
         		 	span.volume                {font-family : courier; font-weight : bold;}
         		 	span.year                  {font-family : courier ; font-style : italic;}
         			
      </style>
   </head>
   <body>
      <div class="front" title="front">
         <div class="journal-meta" tagx="journal-meta" title="journal-meta">
            <span class="nlm-ta" title="nlm-ta">Ann Gen Hosp Psychiatry</span>
            <span class="journal-title" tagx="journal-title" title="journal-title">Annals of General Hospital Psychiatry</span>
            <span class="issn-epub" tagx="issn" title="issn-epub">1475-2832</span>
            <div class="publisher" tagx="publisher" title="publisher">
               <span class="publisher-name" tagx="publisher-name" title="publisher-name">BioMed Central</span>
               <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">London</span>
            </div>
         </div>
         <div class="article-meta" tagx="article-meta" title="article-meta">
            <span class="pmcid" title="pmcid">
               			pmcid:
               			
               <a href="http://www.ncbi.nlm.nih.gov/pubmed/320490">320490</a>
            </span>
            <span class="publisher-id" title="publisher-id">1475-2832-3-1</span>
            <span class="pmid" title="pmid">
               			pmid:
               			
               <a href="http://www.ncbi.nlm.nih.gov/pubmed/14711381">14711381</a>
            </span>
            <span class="doi" title="doi">
               			doi:
               			
               <a href="https://dx.doi.org/10.1186/1475-2832-3-1">10.1186/1475-2832-3-1</a>
            </span>
            <div class="article-categories" title="article-categories">: 
               <span class="subject" title="subject">Primary Research</span>
            </div>
            <div class="title-group">
               <div class="article-title" title="article-title">Behavioral and antioxidant activity of a tosylbenz[g]indolamine derivative. A proposed
                  better profile for a potential antipsychotic agent
               </div>
            </div>
            <div class="contrib-group" title="contrib-group">
               <span class="contrib" title="contrib">
                  <span class="name" tagx="name" title="name">
                     <span class="surname" tagx="surname" title="surname">Zika</span>
                     <span class="given-names" tagx="given-names" title="given-names">Chara A</span>
                  </span>
                  <a href="#I1">1</a>
                  <span class="email" tagx="email" title="email">chzika@pharm.auth.gr</span>
               </span>
               <span class="contrib" title="contrib">
                  <span class="name" tagx="name" title="name">
                     <span class="surname" tagx="surname" title="surname">Nicolaou</span>
                     <span class="given-names" tagx="given-names" title="given-names">Ioannis</span>
                  </span>
                  <a href="#I1">1</a>
                  <span class="email" tagx="email" title="email">Inicolao@pharm.auth.gr</span>
               </span>
               <span class="contrib" title="contrib">
                  <span class="name" tagx="name" title="name">
                     <span class="surname" tagx="surname" title="surname">Gavalas</span>
                     <span class="given-names" tagx="given-names" title="given-names">Antonis</span>
                  </span>
                  <a href="#I1">1</a>
                  <span class="email" tagx="email" title="email">vdem@pharm.auth.gr</span>
               </span>
               <span class="contrib" title="contrib">
                  <span class="name" tagx="name" title="name">
                     <span class="surname" tagx="surname" title="surname">Rekatas</span>
                     <span class="given-names" tagx="given-names" title="given-names">George V</span>
                  </span>
                  <a href="#I1">1</a>
                  <span class="email" tagx="email" title="email">vdem@pharm.auth.gr</span>
               </span>
               <span class="contrib" title="contrib">
                  <span class="name" tagx="name" title="name">
                     <span class="surname" tagx="surname" title="surname">Tani</span>
                     <span class="given-names" tagx="given-names" title="given-names">Ekaterini</span>
                  </span>
                  <a href="#I1">1</a>
                  <span class="email" tagx="email" title="email">vdem@pharm.auth.gr</span>
               </span>
               <span class="contrib" title="contrib">
                  <span class="name" tagx="name" title="name">
                     <span class="surname" tagx="surname" title="surname">Demopoulos</span>
                     <span class="given-names" tagx="given-names" title="given-names">Vassilis J</span>
                  </span>
                  <a href="#I1">1</a>
                  <span class="email" tagx="email" title="email">vdem@pharm.auth.gr</span>
               </span>
            </div>
            <span class="citation_author_institution" id="I1">[1],
               	  
            </span>
            <span class="pub-date-collection" title="pub-date-collection">collection: 
               <span>2004</span>
            </span>
            <span class="pub-date-epub" title="pub-date-epub">epub: 
               <span>2004-1-1</span>
            </span>
            <span class="volume" tagx="volume" title="volume">3</span>
            <span class="fpage" tagx="fpage" title="fpage">1</span>
            <span class="lpage" tagx="lpage" title="lpage">1</span>
            <a href="http://www.general-hospital-psychiatry.com/content/3/1/1"></a>
            <span class="history" title="history">
               <span class="received" title="received">received: 2002-11-29</span>
               <span class="accepted" title="accepted">accepted: 2004-1-7</span>
            </span>
            <div class="permissions">
               <span class="copyright" title="copyright">(C) 
                  <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">Zika et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim
                     copying and redistribution of this article are permitted in all media for any purpose,
                     provided this notice is preserved along with the article's original URL.
                  </span>, 
                  <span class="copyright-year" tagx="copyright-year" title="copyright-year">2004</span>
               </span>
            </div>
            <div class="abstract" title="abstract">
               <div class="abstract-title" title="abstract-title">Abstract</div>
               <div class="background" title="sec">
                  <div class="title" tagx="title" title="title">Background</div>
                  <p>Tardive dyskinesia (TD) is a major limitation of older antipsychotics. Newer antipsychotics
                     have various other side effects such as weight gain, hyperglycemia, etc. In a previous
                     study we have shown that an indolamine molecule expresses a moderate binding affinity
                     at the dopamine D
                     <sub>2 </sub>and serotonin 5-HT
                     <sub>1A </sub>receptors in in vitro competition binding assays. In the present work, we tested its
                     p-toluenesulfonyl derivative (TPBIA) for behavioral effects in rats, related to interactions
                     with central dopamine receptors and its antioxidant activity.
                  </p>
               </div>
               <div class="methods" title="methods">
                  <div class="title" tagx="title" title="title">Methods</div>
                  <p>Adult male Fischer-344 rats grouped as: i) Untreated rats: TPBIA was administered
                     i.p. in various doses ii) Apomorphine-treated rats: were treated with apomorphine
                     (1 mg kg
                     <sup>-1</sup>, i.p.) 10 min after the administration of TPBIA. Afterwards the rats were placed
                     individually in the activity cage and their motor behaviour was recorded for the next
                     30 min The antioxidant potential of TPBIA was investigated in the model of in vitro
                     non enzymatic lipid peroxidation.
                  </p>
               </div>
               <div class="results" title="sec">
                  <div class="title" tagx="title" title="title">Results</div>
                  <p>i) In non-pretreated rats, TPBIA reduces the activity by 39 and 82% respectively,
                     ii) In apomorphine pretreated rats, TPBIA reverses the hyperactivity and stereotype
                     behaviour induced by apomorphine. Also TPBIA completely inhibits the peroxidation
                     of rat liver microsome preparations at concentrations of 0.5, 0.25 and 0.1 mM.
                  </p>
               </div>
               <div class="conclusion" title="sec">
                  <div class="title" tagx="title" title="title">Conclusion</div>
                  <p>TPBIA exerts dopamine antagonistic activity in the central nervous system. In addition,
                     its antioxidant effect is a desirable property, since TD has been partially attributed,
                     to oxidative stress. Further research is needed to test whether TPBIA may be used
                     as an antipsychotic agent.
                  </p>
               </div>
            </div>
         </div>
      </div>
      <div class="body" title="body">
         <div class="background" title="sec">
            <div class="title" tagx="title" title="title">Background</div>
            <p>It is well established that compounds which interact with central dopamine receptors
               have therapeutic potential in the treatment of conditions like Parkinson's disease
               and psychotic disorders. For the later treatment, it is known that tardive dyskinesia
               (TD) is a major limitation of chronic antipsychotic drug therapy at least with older
               (typical) antipsychotics.
            </p>
            <p>There is increased awareness of the different ways in which this condition manifests
               itself and the variety of disabilities that TD produces. Although a substantial research
               has been stimulated to identify the underlying pathophysiological mechanisms of TD,
               they remain largely elusive. There are several hypotheses about the pathophysiology
               of TD (dopamine hypersensitivity, neurotoxicity, GABA insufficiency, noradrenergic
               dysfunction, structural abnormalities)[
               <a href="#B1">1</a>], however the true mechanism remains unknown.
            </p>
            <p>The hypothesis of dopamine hypersensitivity proposes that the nigrostriatal dopamine
               system develops increased sensitivity to dopamine as a consequence of chronic dopamine
               receptor blockade induced by neuroleptic drugs. There is an increased incidence and
               prevalence of involuntary hyperkinetic dyskinesia in patients receiving dopamine antagonists
               in most [
               <a href="#B1">1</a>-
               <a href="#B3">3</a>] but not all reports [
               <a href="#B4">4</a>,
               <a href="#B5">5</a>]. Dopamine antagonists usually suppress TD, whereas dopamine agonists aggravate TD
               symptoms [
               <a href="#B6">6</a>].
            </p>
            <p>An alternate, though highly speculative hypothesis, is the proposal that TD is due
               to neurotoxic effects induced by free radical byproducts from catecholamine metabolism.
               The basal ganglia, by virtue of their high oxidative metabolism, are vulnerable to
               membrane lipid peroxidation as a result of the increased catecholamine turnover induced
               by neuroleptic drugs [
               <a href="#B7">7</a>-
               <a href="#B9">9</a>]. It is known that vitamin E (a-tocopherol) serves as a free radical scavenger, thus
               reducing the cytotoxic effects of free radicals. Clinical studies have produced conflicting
               data in this area. The impression gained from these studies was that while vitamin
               E is safe and well-tolerated, it confers only modest benefits. Some studies do not
               support the hypothesis that TD is mediated through free radical damage to neurons
               [
               <a href="#B8">8</a>,
               <a href="#B10">10</a>,
               <a href="#B11">11</a>] while others support that vitamin E appears to be effective in reducing the severity
               of TD, especially in patients who are young and have recently developed TD [
               <a href="#B12">12</a>,
               <a href="#B13">13</a>].
            </p>
            <p>Early neuroleptic agents showed great antipsychotic promise initially, however, the
               induction of extrapyramidal side effects associated with their use constituted a significant
               problem. Atypical antipsychotics possess a lower extrapyramidal side effects liability
               and show a better efficacy in the treatment of negative and depressive symptoms as
               well as cognitive disorders associated with schizophrenia. These features have been
               related to a higher affinity to serotonin receptors. However, they brought about various
               side effects such as weight gain, hyperglycemia, cholesterol level elevation, and
               QT interval prolongation [
               <a href="#B14">14</a>].
            </p>
            <p>A novel antipsychotic agent with a mechanism of action different from all currently
               marketed typical and atypical antipsychotics is aripiprazole. This quinoline derivative
               exerts potent partial agonistic action on D
               <sub>2 </sub>and 5-HT
               <sub>1A </sub>receptors and antagonistic properties at 5-HT
               <sub>2A </sub>receptors. Aripiprazole claims to be the first agent of a third generation of antipsychotics,
               the so-called "dopamine-serotonin stabilizers"[
               <a href="#B14">14</a>].
            </p>
            <p>In a previous study [
               <a href="#B15">15</a>] we have shown that 6,7,8,9-tetrahydro-N,N,-di-n-propyl-1
               <i>H</i>-benz [g]indole-7-amine (
               <b>PBIA</b>) (Figure 
               <a href="#F1">1</a>) acts 
               <i>in vivo </i>as a functional dopamine receptor partial agonist. It is known that a partial agonist
               at any dose level can not produce the same maximal biological response as a full agonist
               even though the partial agonist binds as tightly and as well to the receptor as the
               full agonist. In sum, a partial agonist has high affinity for its receptor, but low
               intrinsic activity. 
               <b>PBIA </b>is a moderate [
               <sup>3</sup>H]-spiperone and 8-OH-[
               <sup>3</sup>H]-DPAT competitor. Spiperone is a selective D
               <sub>2 </sub>antagonist while 8-OH-DPAT is a selective 5-HT
               <sub>1A </sub>agonist. This means that 
               <b>PBIA </b>expresses a moderate binding affinity at the dopamine D
               <sub>2 </sub>and serotonin 5-HT
               <sub>1A </sub>receptors in 
               <i>in vitro </i>competition binding assays.
            </p>
            <div class="fig" title="fig">
               <div class="figure" title="figure">
                  <a href="http://doi.org/">
                     <span class="label" tagx="label" title="label">Figure 1</span>
                  </a>
               </div>
               <caption class="caption" title="caption">
                  <caption>
                     <p>Structure of 6,7,8,9-tetrahydro-N,N,-di-n-propyl-1
                        <i>H</i>-benz [g]indole-7-amine (PBIA), 1-p-toluenesulfonyl-6,7,8,9-tetrhydro-N,N-di-n-propyl-1
                        <i>H</i>-benz [g]indol-7-amine (TPBIA) and 5-OH-DPAT
                     </p>
                  </caption>
               </caption>
            </div>
            <p>
               <b>PBIA </b>was designed as a metabolically stable bioisostere of the potent dopamine receptor
               agonist 5-OH-DPAT, (Figure 
               <a href="#F1">1</a>). Phenolic dopamine receptor agonists suffer from poor bioavailability due to rapid
               metabolic inactivation via conjugation. Thus, an approach which has been pursued to
               overcome this problem is to develop non phenolic heterocyclic analogues. In this respect,
               evidence indicates that an indole NH moiety can be a bioisostere of the hydrogen-bonding
               H donor properties of the phenolic OH group in dopamine agonists. Based on the above,
               we synthesized 
               <b>PBIA</b>.
            </p>
            <p>In the present work, we tested the derivative 
               <b>2 </b>(Figure 
               <a href="#F1">1</a>), 1-p-toluenesulfonyl-6,7,8,9-tetrhydro-N,N-di-n-propyl-1
               <i>H</i>-benz [g]indol-7-amine (
               <b>TPBIA</b>) for behavioral effects in rats, related to interactions with central dopamine receptors.
               Because 
               <b>TPBIA </b>has an increased lipophilicity and an appropriate polar molecular surface area (PSA)
               value, we hypothesized that it might be capable of penetrating the blood-brain barrier
               in a considerable degree. Additionally, the presence of the tosyl group might shift
               the agonistic activity to that of an antagonist. It is documented that increasing
               the van der Waals molecular volume of an agonist makes it an antagonist [
               <a href="#B16">16</a>]. Finally, since free radical and oxidative stress may be implicated in the pathophysiology
               of a number of neurodegenerative diseases [
               <a href="#B17">17</a>] we also investigated the antioxidant potential of 
               <b>TPBIA</b>, since there are some reports concerning the role of free radicals in TD [
               <a href="#B7">7</a>].
            </p>
            <p>Therefore, it becomes interesting to design compounds that maintain antipsychotic
               efficacy and simultaneously could be free of TD risk.
            </p>
            <p>The aim of the current study was:</p>
            <p>1) to find if 
               <b>TPBIA </b>crosses the blood-brain barrier,
            </p>
            <p>2) to test the behavioral effects of 
               <b>TPBIA </b>with specific focus on neuroleptic effects,
            </p>
            <p>3) to test its antioxidant activity.</p>
         </div>
         <div class="materials_methods" title="materials|methods">
            <div class="title" tagx="title" title="title">Materials and Methods</div>
            <div class="synthesisoftpbia" title="sec">
               <div class="title" tagx="title" title="title">Synthesis of TPBIA</div>
               <p>Key step of the synthesis was a Mukaiyama type aldol condensation between the dimethyl
                  acetal of 1-(
                  <i>p</i>-toluenesulfonyl)pyrrole-3-acetaldehyde and 4-di-
                  <i>n</i>-propylamino-1-trimethylsilyloxycyclohexene followed by cycloaromatization under acidic
                  conditions. A detailed description of the procedures can be found elsewhere [
                  <a href="#B18">18</a>]. TPBIA was isolated as its hydrochloride salt. It was a white crystalline solid
                  with melting point of 209–211°C. The salt was soluble in water in contrast to its
                  free base form.
               </p>
            </div>
            <div class="experimentalanimals" title="sec">
               <div class="title" tagx="title" title="title">Experimental Animals</div>
               <p>Adult male Fischer-344 rats (~250 g) were used.</p>
               <p>The experimental animals were grouped as:</p>
               <p>i. 
                  <i>Group A: Untreated rats</i>: 
                  <b>TPBIA </b>was administered i.p. in various doses and immediately afterwards the rats were placed
                  individually in the activity cage and their motor behavior was recorded for the next
                  30 min.
               </p>
               <p>ii. 
                  <i>Group B: Apomorphine-treated rats</i>: the motor activity was measured as described above in the rats treated with apomorphine
                  (1 mg kg
                  <sup>-1</sup>, i.p.) 10 min after the administration of TPBIA.
               </p>
            </div>
            <div class="biologicalexperimentalprocedure" title="sec">
               <div class="title" tagx="title" title="title">Biological Experimental Procedure</div>
               <div class="invivo" title="sec">
                  <div class="title" tagx="title" title="title">in vivo</div>
                  <p>The experiments were conducted according to a previous reported methodology [
                     <a href="#B15">15</a>]. 
                     <b>TPBIA </b>was converted to its hydrochloride salt and dissolved in water. Apomorphine was dissolved
                     in 1 mM citric acid solution. The motor activity of the rats was measured between
                     12-6 pm in an Ugo-Basile activity cage (type 7401) (Figure 
                     <a href="#F2">2</a>).
                  </p>
                  <div class="fig" title="fig">
                     <div class="figure" title="figure">
                        <a href="http://doi.org/">
                           <span class="label" tagx="label" title="label">Figure 2</span>
                        </a>
                     </div>
                     <caption class="caption" title="caption">
                        <caption>
                           <p>The Ugo-Basile activity cage (type 7401)</p>
                        </caption>
                     </caption>
                  </div>
               </div>
               <div class="invitro" title="sec">
                  <div class="title" tagx="title" title="title">in vitro</div>
                  <p>The antioxidant potential of 
                     <b>TPBIA </b>was investigated in the model of 
                     <i>in vitro </i>non enzymatic lipid peroxidation [
                     <a href="#B19">19</a>].
                  </p>
                  <p>The experiments were conducted according to a previous reported methodology [
                     <a href="#B15">15</a>]. Hepatic microsomal fractions prepared from untreated male Fischer-344 rats were
                     heat-inactivated (90°C, 90 s) and suspended in Tris-HCl/KCl buffer (50 mM/150 mM,
                     pH 7.4). The incubation mixtures contained the microsomal fraction, corresponding
                     to 0.125 g liver mL
                     <sup>-1</sup>, ascorbic acid (0.2 mM) in Tris buffer, and various concentrations (0.01–1 mM) of
                     the tested compounds dissolved in DMSO. An equal volume of the solvent (0.1 mL) was
                     added to the control incubate. The reaction was initiated by adding freshly prepared
                     FeSO
                     <sub>4 </sub>solution (10 μM). The mixture was incubated at 37°C for 45 min. Aliquots (0.3 mL)
                     of the incubation mixture (final volume 4 mL) were taken at various time intervals.
                     Lipid peroxidation was assayed spectrophotometrically (535 nm against 600 nm) by determination
                     of the 2-thiobarbituric acid reactive material.
                  </p>
                  <p>Antioxidants inhibit the production of malondialdehyde and, therefore, the color produced
                     after addition of 2-thiobarbituric acid is less intense. None of the compounds interfered
                     with the assay, neither with the conjugation of 2-thiobarbituric acid or with the
                     absorption at 535–600 nm. Each experiment was performed at least in duplicate. The
                     UV measurements were carried out on a Perkin-Elmer 554 spectrophotometer.
                  </p>
               </div>
            </div>
         </div>
         <div class="results" title="sec">
            <div class="title" tagx="title" title="title">Results</div>
            <p>The effect of the 
               <b>TPBIA </b>on the motor behavior of non treated and apomorphine pretreated rats are shown in
               Tables 
               <a href="#T1">1</a>, 
               <a href="#T2">2</a> and Figure 
               <a href="#F3">3</a>. Apomorphine is a selective agonist of the dopamine D2 receptors. It was found that:
            </p>
            <table-wrap>
               <span class="label" tagx="label" title="label">Table 1</span>
               <caption>
                  <p>Motor behavior of untreated rats</p>
               </caption>
               <table>
                  <thead>
                     <tr>
                        <td>Compound (dose, μmol Kg
                           <sup>-1</sup>)
                        </td>
                        <td>Movements (±SEM) / 30 min</td>
                        <td>Compared with the control group (%)</td>
                     </tr>
                  </thead>
                  <tbody>
                     <tr>
                        <td>Controls</td>
                        <td>263(81)</td>
                        <td>100</td>
                     </tr>
                     <tr>
                        <td>TPBIA(40)</td>
                        <td>161(22)
                           <sup>NS</sup>
                        </td>
                        <td>61</td>
                     </tr>
                     <tr>
                        <td>TPBIA(80)</td>
                        <td>46(16)**</td>
                        <td>18</td>
                     </tr>
                  </tbody>
               </table>
               <table-wrap-foot>
                  <p>
                     <sup>NS</sup>, P &gt; 0.05 (not significant) and **P &lt; 0.01 according to Student's test, n = 3–6
                  </p>
               </table-wrap-foot>
            </table-wrap>
            <table-wrap>
               <span class="label" tagx="label" title="label">Table 2</span>
               <caption>
                  <p>Motor behavior of apomorphine treated rats</p>
               </caption>
               <table>
                  <thead>
                     <tr>
                        <td>Compound (dose, μmol Kg
                           <sup>-1</sup>)
                        </td>
                        <td>Movements (± SEM) / 30 min</td>
                        <td>Compared with the control group (%)</td>
                     </tr>
                  </thead>
                  <tbody>
                     <tr>
                        <td>Apomorphine treated controls</td>
                        <td>385(68)</td>
                        <td>100</td>
                     </tr>
                     <tr>
                        <td>TPBIA(80)</td>
                        <td>113(28)**</td>
                        <td>29</td>
                     </tr>
                  </tbody>
               </table>
               <table-wrap-foot>
                  <p>**P &lt; 0.01 according to Student's test, n = 4</p>
               </table-wrap-foot>
            </table-wrap>
            <div class="fig" title="fig">
               <div class="figure" title="figure">
                  <a href="http://doi.org/">
                     <span class="label" tagx="label" title="label">Figure 3</span>
                  </a>
               </div>
               <caption class="caption" title="caption">
                  <caption>
                     <p>Effect of 
                        <b>TPBIA </b>on the motor behavior of experimental animals
                     </p>
                  </caption>
               </caption>
            </div>
            <p>i. In non-pretreated rats, 
               <b>TPBIA </b>at doses of 40 and 80 μmol/kg reduces the activity by 39 and 82% respectively (Number
               of experimental animals: 3–6).
            </p>
            <p>ii. In apomorphine pretreated rats, 
               <b>TPBIA </b>(80 μmol/kg) reverses the hyperactivity and stereotype behavior induced by apomorphine
               (Number of experimental animals: 4).
            </p>
            <p>The time course of non enzymatic lipid peroxidation as affected by 0.5, 0.25 and 0.1
               mM concentrations of 
               <b>TPBIA </b>is shown in Figure 
               <a href="#F4">4</a>.
            </p>
            <div class="fig" title="fig">
               <div class="figure" title="figure">
                  <a href="http://doi.org/">
                     <span class="label" tagx="label" title="label">Figure 4</span>
                  </a>
               </div>
               <caption class="caption" title="caption">
                  <caption>
                     <p>Time course of lipid peroxidation as affected by various concentrations of 
                        <b>TPBIA</b>.
                     </p>
                  </caption>
               </caption>
            </div>
         </div>
         <div class="discussion" title="sec">
            <div class="title" tagx="title" title="title">Discussion</div>
            <p>The results support our hypothesis that:</p>
            <p>
               <b>a) </b>TPBIA crosses the blood-brain barrier,
            </p>
            <p>
               <b>b) </b>modifies the motor behavior of the experimental animals,
            </p>
            <p>
               <b>c) </b>shows antioxidant activity.
            </p>
            <p>
               <b>a) </b>The Polar Surface Area (PSA) of a molecule is defined as the area of its van der Waals
               surface that arises from oxygen and nitrogen atoms as well as hydrogen atoms attached
               to oxygen or nitrogen atoms. As such, it is clearly related to the capacity of a compound
               to form hydrogen bonds. PSA has been established as a valuable physicochemical parameter
               for the prediction of a number of properties related to the pharmacokinetic profile
               of drugs. Among these properties are the intestinal absorption and the blood-brain
               barrier penetration. PSA has been found to be useful in modeling intestinal absorption
               together with a direct estimate of lipophilicity widely acknowledged as an important
               factor in transport across membranes. A common measure of the degree of BBB penetration
               is the ratio of the steady-state concentrations of the drug molecule in the brain
               and in the blood, usually expressed as log(Cbrain/Cblood). We expect that the increased
               lipophilicity (calculated [
               <a href="#B20">20</a>] ClogP = 6.659) and the small PSA value (calculated [
               <a href="#B21">21</a>], 38.9 Angstroems
               <sup>2</sup>) of this compound will facilitate its central nervous system penetration. Thus by
               using an equation reported by Clark et al [
               <a href="#B22">22</a>] we found that the steady-state distribution of 
               <b>TPBIA </b>between brain and blood is approximately 1000/1 (logBB = 0.58). This computational
               model contains two variables: PSA and calculated logP, both of which can be rapidly
               computed. The model could be considered reliable; for example the measured and predicted
               BBB permeability of the antidepressant drug, amitryptyline were quite similar (experimental
               logBB = 0.76–0.98 and calculated logBB = 0.76). Finally, its low PSA value is a strong
               indication that it could be used 
               <i>per os </i>for systematic use [
               <a href="#B23">23</a>].
            </p>
            <p>
               <b>b) </b>The presented results could suggest that 
               <b>TPBIA </b>acts as a dopamine receptor antagonist in the central nervous system. The tosyl group
               in 
               <b>TPBIA</b>, which plain was found to be perpendicular to that of the indole ring in its low
               energy conformation (Figure 
               <a href="#F4">4</a>) [
               <a href="#B24">24</a>] is important to the differentiation of the biological profile between compounds
               
               <b>PBIA </b>and 
               <b>TPBIA</b>. The association of increasing molecular weight with increasing antagonistic power
               is well known. An antagonist is always bulkier than the corresponding agonist and
               it is obvious that the likelihood of forming extra van der Waals bonds with the receptor
               increases the chances of the bulkier molecule having a longer retention time. Because
               a molecule's kinetic energy of translation (which is an important factor in desorption)
               does not change with increase in molecular weight, any gain in size by the molecule
               increases its time of residence on the receptor [
               <a href="#B16">16</a>].
            </p>
            <p>
               <b>c) </b>Some clinical studies [
               <a href="#B6">6</a>,
               <a href="#B25">25</a>] have shown that vitamin E (a well established antioxidant) may be effective in treating
               TD. However vitamin E does not cross readily the blood-brain barrier [
               <a href="#B26">26</a>], which could explain why other studies failed to confirm these results [
               <a href="#B6">6</a>]. Therefore we considered interesting to investigate the antioxidant potential of
               the synthesized 
               <b>TPBIA</b>. It was found that 
               <b>TPBIA </b>completely inhibits the peroxidation of rat liver microsome preparations at the studied
               concentrations
            </p>
         </div>
         <div class="conclusion" title="sec">
            <div class="title" tagx="title" title="title">Conclusion</div>
            <p>The results of the current study suggest that 
               <b>TPBIA </b>crosses the blood-brain barrier, possesses neuroleptic activity and exerts antioxidative
               activity. The above constitute preliminary 
               <i>in vivo/vitro </i>evidence suggesting that 
               <b>TPBIA </b>could merit further investigation as a potential candidate as an antipsychotic agent
               with novel and clinically important properties.
            </p>
            <p>A putative combination of dopaminergic antagonism and antioxidant activity of a compound
               which readily cross the blood-brain barrier could be of pharmaceutical interest especially
               when the compound is used for the treatment of behavioral disorders in the frame of
               an organic or degenerative mental disorder.
            </p>
            <p>The above results indicate that 
               <b>TPBIA </b>might have therapeutic potential in the treatment of psychosis, due to its dopamine
               antagonistic activity in the central nervous system. In addition, its antioxidant
               effects is a desirable property, since tardive dyskinesia – a neuroleptics' severe
               side effect – has been attributed, at least in part, to oxidative stress.
            </p>
         </div>
         <div class="conflictofinterest" title="sec">
            <div class="title" tagx="title" title="title">Conflict of interest</div>
            <p>None declared.</p>
            <div class="fig" title="fig">
               <div class="figure" title="figure">
                  <a href="http://doi.org/">
                     <span class="label" tagx="label" title="label">Figure 5</span>
                  </a>
               </div>
               <caption class="caption" title="caption">
                  <caption>
                     <p>Low energy conformation and van der Waals surface of compound 
                        <b>TPBIA</b>
                     </p>
                  </caption>
               </caption>
            </div>
         </div>
      </div>
      <div class="back" title="back">
         <div class="ack" title="ack">
            <div class="acknowledgment" title="sec">
               <div class="title" tagx="title" title="title">Acknowledgment</div>
               <p>This work was supported by the grants PENED91ED883 (D.V.J., G.A., R.G.V., T.E.), PENED99ED427
                  (D.V.J., N.I.) and P.D.E., E.P.A.N.-M.4.3.6.1., C.2000 SE 01330005 (D.V.J., N.I.,
                  Z.C.) from the General Secretariat of Research and Technology of Greece as well as
                  from the Public Benefit Foundation Alexander S. Onassis (Z.C.).
               </p>
            </div>
         </div>
         <div class="references">References</div>
         <div tag="ref-list">
            <ul>
               <li tag="ref">
                  <a name="B1"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Bloom</span>
                           <span class="given-names" tagx="given-names" title="given-names">F</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Kupfer</span>
                           <span class="given-names" tagx="given-names" title="given-names">D</span>
                        </span>
                        <span class="etal" title="etal">
                           <i>et al.</i>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Psychopharmacology</div>
                     <span class="source" tagx="source" title="source">The fourth generation of progress</span>
                     <span class="year" tagx="year" title="year">1994</span>
                     <span class="publisher-name" tagx="publisher-name" title="publisher-name">New York: Raven Press</span>
                     <span class="fpage" tagx="fpage" title="fpage">1497</span>
                     <span class="lpage" tagx="lpage" title="lpage">1498</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B2"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Kane</span>
                           <span class="given-names" tagx="given-names" title="given-names">JM</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Woerner</span>
                           <span class="given-names" tagx="given-names" title="given-names">M</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Weinhold</span>
                           <span class="given-names" tagx="given-names" title="given-names">P</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Wegner</span>
                           <span class="given-names" tagx="given-names" title="given-names">J</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Kinon</span>
                           <span class="given-names" tagx="given-names" title="given-names">B</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Borenstein</span>
                           <span class="given-names" tagx="given-names" title="given-names">M</span>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Incidence of Tardive Dyskinesia: Five Year Data from a Prospective Study</div>
                     <span class="source" tagx="source" title="source">Psychopharmacol Bull</span>
                     <span class="year" tagx="year" title="year">1984</span>
                     <span class="volume" tagx="volume" title="volume">20</span>
                     <span class="fpage" tagx="fpage" title="fpage">39</span>
                     <span class="lpage" tagx="lpage" title="lpage">40</span>
                     <span class="pub-id">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/6144134">6144134</a>
                     </span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B3"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Saltz</span>
                           <span class="given-names" tagx="given-names" title="given-names">BL</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Woerner</span>
                           <span class="given-names" tagx="given-names" title="given-names">M</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Kane</span>
                           <span class="given-names" tagx="given-names" title="given-names">JM</span>
                        </span>
                        <span class="etal" title="etal">
                           <i>et al.</i>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Prospective study of tardive dyskinesia incidence in the elderly</div>
                     <span class="source" tagx="source" title="source">JAMA</span>
                     <span class="year" tagx="year" title="year">1991</span>
                     <span class="volume" tagx="volume" title="volume">266</span>
                     <span class="fpage" tagx="fpage" title="fpage">2402</span>
                     <span class="lpage" tagx="lpage" title="lpage">2406</span>
                     <span class="pub-id">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/1681122">1681122</a>
                     </span>
                     <span class="pub-id">
                        <a href="https://dx.doi.org/10.1001/jama.266.17.2402">10.1001/jama.266.17.2402</a>
                     </span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B4"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Waddington</span>
                           <span class="given-names" tagx="given-names" title="given-names">JL</span>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Schizophrenia, affective psychosis and other disorders treated with neuroleptic drugs:
                        the enigma of tardive dyskinesia, its neurobiological determinants and the conflict
                        of paradigms
                     </div>
                     <span class="source" tagx="source" title="source">Int Rev Neurobiol</span>
                     <span class="year" tagx="year" title="year">1989</span>
                     <span class="volume" tagx="volume" title="volume">31</span>
                     <span class="fpage" tagx="fpage" title="fpage">297</span>
                     <span class="lpage" tagx="lpage" title="lpage">353</span>
                     <span class="pub-id">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/2574716">2574716</a>
                     </span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B5"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Waddington</span>
                           <span class="given-names" tagx="given-names" title="given-names">JL</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Youssef</span>
                           <span class="given-names" tagx="given-names" title="given-names">HA</span>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">The lifetime outcome and involuntary movements of schizophrenia never treated with
                        neuroleptic drugs
                     </div>
                     <span class="source" tagx="source" title="source">Br J Psychiatry</span>
                     <span class="year" tagx="year" title="year">1990</span>
                     <span class="volume" tagx="volume" title="volume">156</span>
                     <span class="fpage" tagx="fpage" title="fpage">106</span>
                     <span class="lpage" tagx="lpage" title="lpage">108</span>
                     <span class="pub-id">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/1967543">1967543</a>
                     </span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B6"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Adler</span>
                           <span class="given-names" tagx="given-names" title="given-names">LA</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Edson</span>
                           <span class="given-names" tagx="given-names" title="given-names">R</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Lavori</span>
                           <span class="given-names" tagx="given-names" title="given-names">P</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Peselow</span>
                           <span class="given-names" tagx="given-names" title="given-names">E</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Duncan</span>
                           <span class="given-names" tagx="given-names" title="given-names">E</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Rosenthal</span>
                           <span class="given-names" tagx="given-names" title="given-names">M</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Rostrosen</span>
                           <span class="given-names" tagx="given-names" title="given-names">J</span>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Long-term treatment effects of vitamin E for tardive dyskinesia</div>
                     <span class="source" tagx="source" title="source">Biol Psych</span>
                     <span class="year" tagx="year" title="year">1998</span>
                     <span class="volume" tagx="volume" title="volume">43</span>
                     <span class="fpage" tagx="fpage" title="fpage">868</span>
                     <span class="lpage" tagx="lpage" title="lpage">872</span>
                     <span class="pub-id">
                        <a href="https://dx.doi.org/10.1016/S0006-3223(97)00027-9">10.1016/S0006-3223(97)00027-9</a>
                     </span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B7"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Cadet</span>
                           <span class="given-names" tagx="given-names" title="given-names">JL</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Lohr</span>
                           <span class="given-names" tagx="given-names" title="given-names">JB</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Jeste</span>
                           <span class="given-names" tagx="given-names" title="given-names">DV</span>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Free Radicals and Tardive Dyskinesia</div>
                     <span class="source" tagx="source" title="source">Trends Neurosci</span>
                     <span class="year" tagx="year" title="year">1986</span>
                     <span class="volume" tagx="volume" title="volume">9</span>
                     <span class="fpage" tagx="fpage" title="fpage">107</span>
                     <span class="lpage" tagx="lpage" title="lpage">108</span>
                     <span class="pub-id">
                        <a href="https://dx.doi.org/10.1016/0166-2236(86)90035-4">10.1016/0166-2236(86)90035-4</a>
                     </span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B8"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Lohr</span>
                           <span class="given-names" tagx="given-names" title="given-names">JB</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Cadet</span>
                           <span class="given-names" tagx="given-names" title="given-names">JL</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Lohr</span>
                           <span class="given-names" tagx="given-names" title="given-names">MA</span>
                        </span>
                        <span class="etal" title="etal">
                           <i>et al.</i>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Vitamin E in the treatment of Tardive Dyskinesia. The possible involvement of free
                        Radical Mechanisms
                     </div>
                     <span class="source" tagx="source" title="source">Schizophrenia Bull</span>
                     <span class="year" tagx="year" title="year">1988</span>
                     <span class="volume" tagx="volume" title="volume">14</span>
                     <span class="fpage" tagx="fpage" title="fpage">291</span>
                     <span class="lpage" tagx="lpage" title="lpage">296</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B9"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Lohr</span>
                           <span class="given-names" tagx="given-names" title="given-names">JB</span>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Oxygen Radicals and Neuropsychiatric Ilness, Some speculations</div>
                     <span class="source" tagx="source" title="source">Arch Gen Psychiatry</span>
                     <span class="year" tagx="year" title="year">1991</span>
                     <span class="volume" tagx="volume" title="volume">48</span>
                     <span class="fpage" tagx="fpage" title="fpage">1097</span>
                     <span class="lpage" tagx="lpage" title="lpage">1106</span>
                     <span class="pub-id">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/1845228">1845228</a>
                     </span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B10"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">McCreadie</span>
                           <span class="given-names" tagx="given-names" title="given-names">RG</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">MacDonald</span>
                           <span class="given-names" tagx="given-names" title="given-names">E</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Wiles</span>
                           <span class="given-names" tagx="given-names" title="given-names">D</span>
                        </span>
                        <span class="etal" title="etal">
                           <i>et al.</i>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin
                        E levels in patients with and without tardive dyskinesia, and in normal subjects
                     </div>
                     <span class="source" tagx="source" title="source">Br J Psychiatry</span>
                     <span class="year" tagx="year" title="year">1995</span>
                     <span class="volume" tagx="volume" title="volume">167</span>
                     <span class="fpage" tagx="fpage" title="fpage">610</span>
                     <span class="lpage" tagx="lpage" title="lpage">617</span>
                     <span class="pub-id">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/8564316">8564316</a>
                     </span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B11"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Adler</span>
                           <span class="given-names" tagx="given-names" title="given-names">LA</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Peselow</span>
                           <span class="given-names" tagx="given-names" title="given-names">E</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Rotrosen</span>
                           <span class="given-names" tagx="given-names" title="given-names">J</span>
                        </span>
                        <span class="etal" title="etal">
                           <i>et al.</i>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Vitamine E treatment of Tardive Dyskinesia</div>
                     <span class="source" tagx="source" title="source">Am J Psychiat</span>
                     <span class="year" tagx="year" title="year">1993</span>
                     <span class="volume" tagx="volume" title="volume">150</span>
                     <span class="fpage" tagx="fpage" title="fpage">1405</span>
                     <span class="lpage" tagx="lpage" title="lpage">1407</span>
                     <span class="pub-id">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/8102511">8102511</a>
                     </span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B12"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Lohr</span>
                           <span class="given-names" tagx="given-names" title="given-names">JB</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Caligiuri</span>
                           <span class="given-names" tagx="given-names" title="given-names">MP</span>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia</div>
                     <span class="source" tagx="source" title="source">J Clin Psychiatry</span>
                     <span class="year" tagx="year" title="year">1996</span>
                     <span class="volume" tagx="volume" title="volume">57</span>
                     <span class="fpage" tagx="fpage" title="fpage">167</span>
                     <span class="lpage" tagx="lpage" title="lpage">173</span>
                     <span class="pub-id">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/8601552">8601552</a>
                     </span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B13"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Shriqui</span>
                           <span class="given-names" tagx="given-names" title="given-names">CL</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Bradwejn</span>
                           <span class="given-names" tagx="given-names" title="given-names">J</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Annable</span>
                           <span class="given-names" tagx="given-names" title="given-names">L</span>
                        </span>
                        <span class="etal" title="etal">
                           <i>et al.</i>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled
                        study
                     </div>
                     <span class="source" tagx="source" title="source">Am J Psychiatry</span>
                     <span class="year" tagx="year" title="year">1992</span>
                     <span class="volume" tagx="volume" title="volume">149</span>
                     <span class="fpage" tagx="fpage" title="fpage">391</span>
                     <span class="lpage" tagx="lpage" title="lpage">393</span>
                     <span class="pub-id">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/1346951">1346951</a>
                     </span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B14"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Bandelow</span>
                           <span class="given-names" tagx="given-names" title="given-names">B</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Meier</span>
                           <span class="given-names" tagx="given-names" title="given-names">A</span>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Aripiprazole, a "Dopamine-Serotonin System Stabilizer" in the treatment of Psychosis</div>
                     <span class="source" tagx="source" title="source">Reprinted from the German Journal of Psychiatry</span>
                     <a href="http://www.gipsy.uni-goettingen.de"></a>
                     <span class="comment">ISSN 1433-1055</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B15"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Demopoulos</span>
                           <span class="given-names" tagx="given-names" title="given-names">VJ</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Gavalas</span>
                           <span class="given-names" tagx="given-names" title="given-names">A</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Rekatas</span>
                           <span class="given-names" tagx="given-names" title="given-names">G</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Tani</span>
                           <span class="given-names" tagx="given-names" title="given-names">Ek</span>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Activity on the cns andantioxidant profile of two benzo[g]indolamine derivatives</div>
                     <span class="source" tagx="source" title="source">Med Chem Res</span>
                     <span class="year" tagx="year" title="year">1999</span>
                     <span class="volume" tagx="volume" title="volume">9</span>
                     <span class="fpage" tagx="fpage" title="fpage">9</span>
                     <span class="lpage" tagx="lpage" title="lpage">18</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B16"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Albert</span>
                           <span class="given-names" tagx="given-names" title="given-names">A</span>
                        </span>
                     </span>
                     <span class="source" tagx="source" title="source">Selective Toxicity, The physico-chemical basis of therapy</span>
                     <span class="year" tagx="year" title="year">1985</span>
                     <span class="edition" tagx="edition" title="edition">7</span>
                     <span class="publisher-name" tagx="publisher-name" title="publisher-name">New York: Chapman and Hall</span>
                     <span class="fpage" tagx="fpage" title="fpage">294</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B17"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Gerlach</span>
                           <span class="given-names" tagx="given-names" title="given-names">M</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Riederer</span>
                           <span class="given-names" tagx="given-names" title="given-names">P</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Youdim</span>
                           <span class="given-names" tagx="given-names" title="given-names">MBH</span>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Neuroprotective Therapeutic Strategies-Comparison of experimental and Clinical Results</div>
                     <span class="source" tagx="source" title="source">Biochem Pharmacol</span>
                     <span class="year" tagx="year" title="year">1995</span>
                     <span class="volume" tagx="volume" title="volume">50</span>
                     <span class="fpage" tagx="fpage" title="fpage">1</span>
                     <span class="lpage" tagx="lpage" title="lpage">16</span>
                     <span class="pub-id">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/7605334">7605334</a>
                     </span>
                     <span class="pub-id">
                        <a href="https://dx.doi.org/10.1016/0006-2952(95)00051-Z">10.1016/0006-2952(95)00051-Z</a>
                     </span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B18"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Demopoulos</span>
                           <span class="given-names" tagx="given-names" title="given-names">VJ</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Gavalas</span>
                           <span class="given-names" tagx="given-names" title="given-names">A</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Rekatas</span>
                           <span class="given-names" tagx="given-names" title="given-names">G</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Tani</span>
                           <span class="given-names" tagx="given-names" title="given-names">Ek</span>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Synthesis of 6,7,8,9-Tetrahydro-N,N-Fi-Propyl-1H-Benz[g]indol-7-amine. A Potential
                        Dopamine Receptor Agonist
                     </div>
                     <span class="source" tagx="source" title="source">J Heterocyclic Chem</span>
                     <span class="year" tagx="year" title="year">1995</span>
                     <span class="volume" tagx="volume" title="volume">32</span>
                     <span class="fpage" tagx="fpage" title="fpage">1145</span>
                     <span class="lpage" tagx="lpage" title="lpage">1148</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B19"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Rekka</span>
                           <span class="given-names" tagx="given-names" title="given-names">E</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Kolstee</span>
                           <span class="given-names" tagx="given-names" title="given-names">J</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Timmerman</span>
                           <span class="given-names" tagx="given-names" title="given-names">H</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Bast</span>
                           <span class="given-names" tagx="given-names" title="given-names">A</span>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">The effect of some H-2-receptor Antagonists on rat Hepatic Microsomal cytochrome P-450
                        and lipid Peroxidation in vitro
                     </div>
                     <span class="source" tagx="source" title="source">Eur J Med Chem</span>
                     <span class="year" tagx="year" title="year">1989</span>
                     <span class="volume" tagx="volume" title="volume">24</span>
                     <span class="fpage" tagx="fpage" title="fpage">43</span>
                     <span class="lpage" tagx="lpage" title="lpage">47</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B20"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <div class="article-title" title="article-title">ClogP Version 4.72</div>
                     <span class="source" tagx="source" title="source">Daylight Chemical Information Systems Inc</span>
                     <a href="http://www.daylight.com/"></a>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B21"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Demopoulos</span>
                           <span class="given-names" tagx="given-names" title="given-names">VJ</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Anagnostou</span>
                           <span class="given-names" tagx="given-names" title="given-names">C</span>
                        </span>
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Nicolaou</span>
                           <span class="given-names" tagx="given-names" title="given-names">I</span>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Validation of a computational procedure for the calculation of the polar surface area
                        (PSA) of organic compounds
                     </div>
                     <span class="source" tagx="source" title="source">Pharmazie</span>
                     <span class="year" tagx="year" title="year">2002</span>
                     <span class="volume" tagx="volume" title="volume">57</span>
                     <span class="fpage" tagx="fpage" title="fpage">652</span>
                     <span class="lpage" tagx="lpage" title="lpage">653</span>
                     <span class="pub-id">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12369459">12369459</a>
                     </span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B22"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Clark</span>
                           <span class="given-names" tagx="given-names" title="given-names">DE</span>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Rapid calculation of polar molecular surface area and its application to the prediction
                        of transport phenomena. 2. Prediction of blood-brain barrier penetration
                     </div>
                     <span class="source" tagx="source" title="source">J Pharm Sci</span>
                     <span class="year" tagx="year" title="year">1999</span>
                     <span class="volume" tagx="volume" title="volume">88</span>
                     <span class="fpage" tagx="fpage" title="fpage">815</span>
                     <span class="lpage" tagx="lpage" title="lpage">821</span>
                     <span class="pub-id">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/10430548">10430548</a>
                     </span>
                     <span class="pub-id">
                        <a href="https://dx.doi.org/10.1021/js980402t">10.1021/js980402t</a>
                     </span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B23"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Clark</span>
                           <span class="given-names" tagx="given-names" title="given-names">DE</span>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Rapid calculation of polar molecular surface area and its application to the prediction
                        of transport phenomena. 1. Prediction of intestinal absorption
                     </div>
                     <span class="source" tagx="source" title="source">J Pharm Sci</span>
                     <span class="year" tagx="year" title="year">1999</span>
                     <span class="volume" tagx="volume" title="volume">88</span>
                     <span class="fpage" tagx="fpage" title="fpage">808</span>
                     <span class="lpage" tagx="lpage" title="lpage">814</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B24"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <div class="article-title" title="article-title">SPARTAN SGI Version 5.1.3 OpenGL, Wavefunction, Inc., 18401 Von Karman Avenue, Suite
                        370, Irvine, CA 92612 U.S.A
                     </div>
                     <span class="comment">[Method: RHF/6-311G** on a low energy conformer generated from a Monte Carlo search]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B25"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Jackson-Lewis</span>
                           <span class="given-names" tagx="given-names" title="given-names">V</span>
                        </span>
                        <span class="etal" title="etal">
                           <i>et al.</i>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Partial Attenuation of Chronic Fluphenazine-induced Changes in Regional Monoamine
                        Metabolism by D-Alpha-Tocopherol in Rat-brain
                     </div>
                     <span class="source" tagx="source" title="source">Brain Res Bull</span>
                     <span class="year" tagx="year" title="year">1991</span>
                     <span class="volume" tagx="volume" title="volume">26</span>
                     <span class="fpage" tagx="fpage" title="fpage">251</span>
                     <span class="lpage" tagx="lpage" title="lpage">258</span>
                     <span class="pub-id">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/1707329">1707329</a>
                     </span>
                     <span class="pub-id">
                        <a href="https://dx.doi.org/10.1016/0361-9230(91)90235-C">10.1016/0361-9230(91)90235-C</a>
                     </span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B26"></a>
                  <div class="citation" tagx="citation" title="citation">
                     <span class="person-group'">
                        <span class="name" tagx="name" title="name">
                           <span class="surname" tagx="surname" title="surname">Vatassery</span>
                           <span class="given-names" tagx="given-names" title="given-names">GT</span>
                        </span>
                        <span class="etal" title="etal">
                           <i>et al.</i>
                        </span>
                     </span>
                     <div class="article-title" title="article-title">Concentrations of Vitamin E in various Neuroanatomical Regions and Subcellular Fractions,
                        and The Uptake of Vitamin E by specific Areas of Rat Brain
                     </div>
                     <span class="source" tagx="source" title="source">Biochim Biophys Acta</span>
                     <span class="year" tagx="year" title="year">1984</span>
                     <span class="volume" tagx="volume" title="volume">792</span>
                     <span class="fpage" tagx="fpage" title="fpage">118</span>
                     <span class="lpage" tagx="lpage" title="lpage">122</span>
                     <span class="pub-id">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/6696923">6696923</a>
                     </span>
                     <span class="pub-id">
                        <a href="https://dx.doi.org/10.1016/0005-2760(84)90211-X">10.1016/0005-2760(84)90211-X</a>
                     </span>
                  </div>
               </li>
            </ul>
         </div>
      </div>
   </body>
</html>